Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments
<p>Like many other cell surface receptors, the CD95 (APO-1/Fas) molecule needs to be cross-linked by its physiological ligand or by immobilized or multimeric antibodies to mediate biological activity, that is, induction of apoptotic cell death. Monomeric CD95 antibodies of the IgG2a or IgG1 su...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
March 1, 2001
|
| In: |
Cancer research
Year: 2001, Volume: 61, Issue: 5, Pages: 1846-1848 |
| ISSN: | 1538-7445 |
| Online Access: | Verlag, Volltext: https://cancerres.aacrjournals.org/content/61/5/1846
|
| Author Notes: | Gundram Jung, Ludger Grosse-Hovest, Peter H. Krammer, and Hans-Georg Rammensee |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1755928513 | ||
| 003 | DE-627 | ||
| 005 | 20220819181541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210426s2001 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1755928513 | ||
| 035 | |a (DE-599)KXP1755928513 | ||
| 035 | |a (OCoLC)1341406080 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jung, Gundram |d 1953- |e VerfasserIn |0 (DE-588)141776633 |0 (DE-627)631189394 |0 (DE-576)322738334 |4 aut | |
| 245 | 1 | 0 | |a Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments |c Gundram Jung, Ludger Grosse-Hovest, Peter H. Krammer, and Hans-Georg Rammensee |
| 264 | 1 | |c March 1, 2001 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 26.04.2021 | ||
| 520 | |a <p>Like many other cell surface receptors, the CD95 (APO-1/Fas) molecule needs to be cross-linked by its physiological ligand or by immobilized or multimeric antibodies to mediate biological activity, that is, induction of apoptotic cell death. Monomeric CD95 antibodies of the IgG2a or IgG1 subtype block rather than induce apoptosis. We report here that such antibodies, hybridized to a second antibody directed against a different target antigen on the same cell, effectively induce apoptosis of the cells if the expression of the target antigen exceeds a certain threshold level. It appears that this effect is due to bicellular binding of bispecific antibodies resulting in mutual cross-linking of the CD95 death receptor and the target antigen. Using bispecific reagents, it may therefore be possible to restrict the activation of death receptors to a given target site, <i>e.g.</i>, a tumor. In general terms, our findings illustrate a principle according to which the triggering of a cell surface receptor may be confined to a given target cell using bispecific reagents with target X cell surface receptor specificity.</p> | ||
| 700 | 1 | |a Krammer, Peter H. |d 1946- |e VerfasserIn |0 (DE-588)121766373 |0 (DE-627)081520255 |0 (DE-576)292873417 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer research |d Philadelphia, Pa. : AACR, 1941 |g 61(2001), 5, Seite 1846-1848 |h Online-Ressource |w (DE-627)325489955 |w (DE-600)2036785-5 |w (DE-576)094502226 |x 1538-7445 |7 nnas |a Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments |
| 773 | 1 | 8 | |g volume:61 |g year:2001 |g number:5 |g pages:1846-1848 |g extent:4 |a Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments |
| 856 | 4 | 0 | |u https://cancerres.aacrjournals.org/content/61/5/1846 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210426 | ||
| 993 | |a Article | ||
| 994 | |a 2001 | ||
| 998 | |g 121766373 |a Krammer, Peter H. |m 121766373:Krammer, Peter H. |d 50000 |e 50000PK121766373 |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1755928513 |e 3917717794 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1755928513","note":["Gesehen am 26.04.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Jung, Gundram","roleDisplay":"VerfasserIn","role":"aut","family":"Jung","given":"Gundram"},{"role":"aut","display":"Krammer, Peter H.","roleDisplay":"VerfasserIn","given":"Peter H.","family":"Krammer"}],"title":[{"title":"Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments","title_sort":"Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments"}],"relHost":[{"name":{"displayForm":["American Association for Cancer Research"]},"id":{"issn":["1538-7445"],"zdb":["2036785-5"],"eki":["325489955"]},"origin":[{"publisherPlace":"Philadelphia, Pa.","dateIssuedDisp":"1941-","publisher":"AACR","dateIssuedKey":"1941"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Cancer research","title":"Cancer research"}],"recId":"325489955","language":["eng"],"corporate":[{"display":"American Association for Cancer Research","roleDisplay":"Herausgebendes Organ","role":"isb"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragmentsCancer research","note":["Gesehen am 31.03.25","Fortsetzung der Druck-Ausgabe"],"part":{"issue":"5","pages":"1846-1848","year":"2001","extent":"4","volume":"61","text":"61(2001), 5, Seite 1846-1848"},"pubHistory":["Volume 1, issue 1 (1 January 1941)-"]}],"physDesc":[{"extent":"4 S."}],"name":{"displayForm":["Gundram Jung, Ludger Grosse-Hovest, Peter H. Krammer, and Hans-Georg Rammensee"]},"id":{"eki":["1755928513"]},"origin":[{"dateIssuedKey":"2001","dateIssuedDisp":"March 1, 2001"}]} | ||
| SRT | |a JUNGGUNDRATARGETCELL1200 | ||